Finoriq research workspace
ANI PHARMACEUTICALS INC (ANIP) Institutional Holdings & 13F Ownership
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets. Review ANIP institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
- Company
- ANI PHARMACEUTICALS INC (ANIP)
- Ticker
- ANIP
- Market Cap
- $1.8B
- Latest Price
- $78.2
- Industry
- Biotech & Pharma
ANI PHARMACEUTICALS INC (ANIP) Top Institutional Holders
Top current 13F holders indexed for ANI PHARMACEUTICALS INC (ANIP). Latest period 2026-03-31.
| Rank | Investor | Value | Portfolio | Filing |
|---|---|---|---|---|
| 1 | Hotchkis & WileyCIK 0001164833 | $6.4M | 0.02% | Filing2026-05-15 |
| 2 | Joel GreenblattCIK 0001510387 | $1.9M | 0.01% | Filing2026-05-15 |
| 3 | Polen Capital ManagementCIK 0001034524 | $492,852 | 0.0% | Filing2026-05-14 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.